Physician profile
Derek Cuff
NPI 1629036603
$4,089,314.26
in general payments reported to CMS, 2019-2025
13 companies · $1.1M in 2025
The $1.1M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63K · 2020: $24K · 2021: $870K · 2022: $823K · 2023: $709K · 2024: $473K · 2025: $1.1M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.2M · Consulting Fee: $121K · Travel and Lodging: $5,978 · Food and Beverage: $1,920 · Education: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,180,643.51 |
| Consulting Fee | $120,549.00 |
| Travel and Lodging | $5,978.09 |
| Food and Beverage | $1,919.58 |
| Education | $297.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ignite Orthopedics, LLC | $2,641,629.81 | 2019-2025 | |
| Depuy Synthes Products, INC. | $1,155,570.19 | 2021-2025 | Inhance, Na |
| Medical Device Business Services, INC. | $195,917.30 | 2019-2025 | Inhance, Dynacord, Attune |
| Encore Medical, Lp | $94,094.97 | 2019-2022 | |
| Stryker Corporation | $1,275.40 | 2019-2024 | Actishield, Mako |
| Zimmer Biomet Holdings, INC. | $396.89 | 2019-2025 | Quattro, Juggerknotless Soft Anchor |
| Depuy Synthes Sales INC. | $171.23 | 2021-2024 | Inhance |
| Smith+Nephew, INC. | $164.93 | 2022-2025 | Healicoil, Q-Fix, Firstpass |
| Mvp Orthopedics INC | $40.77 | 2021 | |
| Arthrex, INC. | $21.93 | 2025 | |
| Coastal Medical Technologies LLC | $13.44 | 2023 | |
| Ossur Americas, INC. | $12.44 | 2024 | Miami J |
| Heraeus Medical, LLC. | $4.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$14,420,250.21 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Cuff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.